Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

被引:410
|
作者
Takahashi, Yoshihisa [1 ]
Soejima, Yurie [1 ]
Fukusato, Toshio [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
关键词
Animal model; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Histopathology; ACTIVATED-RECEPTOR-ALPHA; CHOLINE-DEFICIENT DIET; METHIONINE ADENOSYLTRANSFERASE 1A; FRUCTOSE-ENRICHED DIETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DB/DB MICE; HEPATIC INFLAMMATION; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I
10.3748/wjg.v18.i19.2300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2300 / 2308
页数:9
相关论文
共 50 条
  • [41] Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Shan, Guan-Yue
    Wan, Hui
    Zhang, Yu-Xin
    Cheng, Jun-Ya
    Qiao, Duan-Rui
    Liu, Yi-Ying
    Shi, Wen-Na
    Li, Hai-Jun
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (10)
  • [42] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Cha J.-Y.
    Kim D.-H.
    Chun K.-H.
    Laboratory Animal Research, 2018, 34 (4) : 133 - 139
  • [43] Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Beaton, Melanie D.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (06) : 353 - 357
  • [44] Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair M.
    Henry, Linda
    Bush, Haley
    Mishra, Alita
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 1 - +
  • [45] The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
    Saadeh, S
    Younossi, ZM
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2000, 67 (02) : 96 - +
  • [46] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [47] Predictors of steatohepatitis in nonalcoholic fatty liver disease
    Ozturk, Kadir
    Demirci, Hakan
    Kurt, Omer
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (05) : 606 - 607
  • [48] CARDIOVASCULAR RISK FACTORS IN NONALCOHOLIC FATTY LIVER DISEASE/NONALCOHOLIC STEATOHEPATITIS
    Ivanova, R.
    Gospodinova, M.
    Petrova, J.
    Alexiev, A.
    Denchev, S.
    Mateva, L.
    ATHEROSCLEROSIS, 2014, 235 (02) : E240 - E240
  • [49] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Sugimoto, Keiichiro
    Inui, Hiroshi
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3777 - 3785
  • [50] The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Chow, Monica D.
    Lee, Yi-Horng
    Guo, Grace L.
    MOLECULAR ASPECTS OF MEDICINE, 2017, 56 : 34 - 44